APEX
IPO ACCESS
INVESTMENT INTELLIGENCE
Set yourself up for potential access to the SpaceX and xAI IPOs and other Musk-ecosystem new-issue offerings.
Position yourself for direct allocation in one of the most anticipated public offerings of the decade. APEX IPO ACCESS provides qualified investors a structured pathway into SpaceX's IPO — bypassing the retail scramble and securing placement before the public window opens.
A registration statement has been filed with the SEC but is not yet effective. No offer to buy may be accepted prior to effectiveness. All allocations subject to availability and underwriter discretion.
Indicate your interest in xAI's anticipated public offering. APEX clients receive direct allocation notifications and priority placement consideration when shares become available.
Explore a wide range of new issue securities as they come to market.
The process companies use to list and offer shares on the public markets for the first time.
The sale of shares of a company that already trades on the public markets.
Allocations in late-stage private companies before they reach the public market — including SpaceX and xAI.
Be sure it's fully funded before the offering window closes.
Open an accountSelect SpaceX, xAI, or any other available offering — and specify your target allocation size.
Indicate interestComplete an investor profile to confirm eligibility — then review the prospectus and submit a conditional offer to buy.
Submit conditional offer* Submission of a conditional offer does not guarantee participation or allocation. APEX IPO ACCESS allocates shares at the discretion of the issuer and underwriters — you may receive fewer shares than requested, or no allocation at all.
Open and fund a new qualified brokerage account with a qualifying deposit by 6/30/2026. Terms apply. Use promo code: APEX1500
Learn howSpaceX and xAI represent the largest private-to-public transitions of the decade. APEX IPO ACCESS exists for one reason: to put qualified investors in position before the bell rings.
No public roadshow. No retail scramble. Direct allocation pathway through the Birchall family-office network.
APEX IPO ACCESS delivers institutional-grade investment opportunities, allocation intelligence, and direct pathways into private placements — purpose-built for accredited investors building positions ahead of liquidity events.
Important Regulatory Disclosure. Participation in any initial public offering, secondary offering, or private placement is subject to availability, investor eligibility, suitability review, and the sole discretion of the issuer, underwriters, and APEX IPO ACCESS. New-issue and private-market securities involve a high degree of risk, including illiquidity, valuation uncertainty, and potential loss of principal. Past performance is not indicative of future results. APEX IPO ACCESS does not guarantee allocation, fill quantity, or pricing on any offering. All securities are offered solely by prospectus or offering memorandum, which should be read in full prior to investment. APEX IPO ACCESS is a private allocation network serving verified accredited and institutional investors only. See our Risk Disclosure, Form CRS, Terms of Service, and Privacy Policy for additional information.